Overview
- Provides full coverage of established and emerging therapies, including novel targeted and antiangiogenic agents
- Evaluates the mechanisms of drug resistance and the therapeutic potential of new targets
- Integrates molecular biology into strategies for prevention and treatment of lung cancer
- Includes supplementary material: sn.pub/extras
Part of the book series: Current Clinical Oncology (CCO)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (20 chapters)
Keywords
About this book
Reviews
From the reviews:
“This comprehensive review of prevention and treatment strategies for malignancies of the thorax thoroughly investigates tumor biology and discusses established and emerging therapies. … The book is written for a wide audience that includes pathologists, pulmonologists, medical oncologists, radiation oncologists, and surgical oncologists. … I would highly recommend this book to anyone interested in current and future therapies for lung cancer. This is one of the most comprehensive and up-to-date accounts of the field.” (Nagendra S. Koneru, Doody’s Review Service, July, 2010)Editors and Affiliations
Bibliographic Information
Book Title: Lung Cancer:
Book Subtitle: Prevention, Management, and Emerging Therapies
Editors: David J. Stewart
Series Title: Current Clinical Oncology
DOI: https://doi.org/10.1007/978-1-60761-524-8
Publisher: Humana Totowa, NJ
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Humana Press 2010
Hardcover ISBN: 978-1-60761-523-1Published: 04 March 2010
Softcover ISBN: 978-1-61779-684-5Published: 06 April 2012
eBook ISBN: 978-1-60761-524-8Published: 10 March 2010
Series ISSN: 2364-1134
Series E-ISSN: 2364-1142
Edition Number: 1
Number of Pages: XVI, 538
Number of Illustrations: 16 b/w illustrations, 14 illustrations in colour
Topics: Pneumology/Respiratory System, Oncology, Radiotherapy, Medical Biochemistry